Profound Medical (TSX:PRN) Total Equity : C$86.08 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Profound Medical Total Equity?

Profound Medical's total equity for the quarter that ended in Dec. 2024 was C$86.08 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Profound Medical Total Equity Historical Data

The historical data trend for Profound Medical's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profound Medical Total Equity Chart

Profound Medical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Equity

Get a 7-Day Free Trial

124.70

103.19

70.65

41.89

86.08

Profound Medical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Equity	Get a 7-Day Free Trial															41.89	62.07	53.78	42.08	86.08

Profound Medical Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Profound Medical's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	100.062	-	13.979
	=	86.08

Profound Medical's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	100.062	-	13.979
	=	86.08

Profound Medical Total Equity Related Terms

Thank you for viewing the detailed overview of Profound Medical's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Profound Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (TSX:PRN) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

PROF:USA

Address

2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5

Website

https://www.profoundmedical.com

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Executives

Dr. Arun Menawat	Director, Senior Officer
Thomas Michael Tamberrino	Senior Officer
Rashed Osman Dewan	Senior Officer
Abbey Klair Goodman	Senior Officer
Brian Ellacott	Director
Murielle Lortie	Director
Arthur Lee Rosenthal	Director
Aaron Davidson	Senior Officer
Guruprit Kour Singh	Senior Officer
Ian Heynen	Senior Officer